Frankfurt / Singapore - September 13, 2012 (Investorideas.com newswire) Nanostart Asia Pacific is preparing an additional fundraising of up to 4 million SGD for its further expansion. A large part of the amount has already been committed. As in the previous funding in February 2012, the money comes from the existing shareholders and new investors based in the region. It shall be used for follow up funding the existing portfolio. Furthermore Nanostart Asia Pacific is already working on new investment opportunities.
In addition the company has formed an advisory board with renowned experts in order to support the further development of the company. The board will initially comprise of Harry De Wit, President Asia with Covidien, Prof. Dr. Uwe Klima, Head of Cardiosurgery at the American Hospital Dubai, Günter Mayer, Senior Manager with Infineon, Jürgen Binzer, Entrepreneur and Vice President with Hollingsworth & Vose in Germany and Chua Hong Moh, Entrepreneur from Singapore . The advisors will support the company’s further development and its expansion in Asia by providing their expertise as well as their broad network.
The announcement is made during the event "Investing in Singapore Nanotechnology" at Singapore Polytechnic, where Nanostart Asia Pacific and Singapore Polytechnic jointly feature their activities in the nano- and high-tech space to the investment and business community.
Nanostart AG headquartered in the German financial capital of Frankfurt, is a leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore . The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences and IT/electronics. As main shareholder of Nanostart Asia Pacific Ptd Ltd, Nanostart invests as partner of the Singapore government.
About Nanostart Asia Pacific:
Nanostart Asia Pacific Pte Ltd was established in Singapore in 2012 with the goal to explore the growth markets of Asia . As a venture capital investment company, Nanostart Asia Pacific invests in young, up-and-coming nanotechnology companies which are approaching market launch or have innovative products already on the market. In Singapore , it invests as a partner of Singapore government via Nanostart Singapore Early-Stage Venture Fund I Pte Ltd. It is a subsidiary of Nanostart AG. Other shareholders of Nanostart Asia Pacific besides Nanostart AG are a number of strategic venture capital investors out of Asia, who with their network and experience are set to facilitate Nanostart's expansion in Asia , and the company’s management. For more information about Nanostart Asia Pacific, please visit: www.nanostart-asia-pacific.com
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the "Entry Standard" segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within Canada, Australia or Japan.
Nanostart AG Dr. Hans Joachim Duerr Head of Corporate Communications Goethestrasse 26-28 60313 Frankfurt , Germany phone: +49 (0)69-21 93 96 111 fax: +49 (0)69-21 93 96 150 e-mail: email@example.com
This news is published on the Investorideas.com Newswire and its syndicated partner network
Published at the Investorideas.com Newswire - Big ideas for Global Investors
Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.